Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.19.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
6 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Advertising expenses $ 32,446 $ 34,522
Applied Products LLC [Member]    
Owned interest entity 100.00%  
Revenue - sale $ 169,654 59,400
Trace Analytics [Member]    
Owned interest entity 51.00%  
Revenue - sale $ 286,077
Applied Biopharma LLC [Member] | SHL Management LLC [Member]    
Owned interest entity 100.00%  
VitaCBD LLC [Member]    
Owned interest entity 80.00%